Idorsia Pharmaceuticals
Presence
Idorsia Pharmaceuticals is a company listed under the stock ticker IDIA (CH).
Idorsia Pharmaceuticals has a direct presence in 2 countries.
Executives
View the org chart displaying its 32 main executives
Most searched biographies at Idorsia Pharmaceuticals
- Jean-Paul Clozel, Chief Executive Officer (retiring on Jun 13 2024)
- Srishti Gupta, Director
- Mathieu Simon, Chairman of the Board
Popular executive movements at Idorsia Pharmaceuticals
- Jean-Paul Clozel, Chief Executive Officer, will retire on Jun. 13, 2024 (posted on May 22 2024).
- Andre Muller who is Executive Vice President and Chief Financial Officer, will be promoted to Chief Executive Officer on Jun. 13, 2024 (posted on May 22 2024).
- Guy Braunstein, Executive Vice President and Chief Medical Officer, will retire on Mar. 31, 2024 (posted on March 24 2024).
Click here to view some more movements at Idorsia Pharmaceuticals
Create your alert
to follow the executive moves at Idorsia Pharmaceuticals.
Pharmaceuticals
Idorsia Pharmaceuticals has 1,857 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Sanofi (France).
Popular M&A news in Pharmaceuticals
- LakeShore Biopharma will change its company name to LakeShore Biopharma on May 24, 2024. (posted on May 25 2024).
- MedMen has filed for bankruptcy protection (posted on April 28 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Idorsia Pharmaceuticals
Social media about Idorsia Pharmaceuticals
- Idorsia Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
- Idorsia Pharmaceuticals on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Jean-Paul Clozel 
Call Idorsia Pharmaceuticals at +41 58...
